Confido Health is a technology company.
Confido Health has raised $10.0M across 1 funding round.
Confido Health has raised $10.0M in total across 1 funding round.
Confido Health has raised $10.0M in total across 1 funding round.
Confido Health's investors include Battery Ventures, Blume Ventures, Khosla Ventures, Okta Ventures, Storm Ventures.
Confido Health is a technology company developing AI-powered voice agents tailored for healthcare practices. These agents handle patient calls and texts, automating tasks like appointment booking, refills, eligibility checks, referrals, payments, and status updates while integrating seamlessly with electronic health records (EHR) and practice management systems (PMS).[1][2] Serving multi-site operators, private equity-backed groups, and specialties including pediatrics, orthopedics, GI, nephrology, dermatology, and pain medicine, Confido solves the problem of phone call overload—where less than half of patient calls resolve on the first attempt—by providing 24/7 access, 80%+ automation rates, and instant resolutions.[1][2] The company has shown strong growth momentum, expanding 10x in eight months to serve over 1 million patients (from 150,000 in December 2024), saving staff up to 2 hours daily and reducing wait times dramatically, as seen at Dallas Renal Group where inbound waits dropped to 15 seconds and outbound appointment confirmations hit 66%.[1][2]
Confido Health emerged to address inefficiencies in healthcare's "most common patient front door"—phone calls—by deploying AI voice agents that replace fragmented phone trees with intelligent, one-shot resolutions.[1] While specific founders are not detailed in available sources, the company gained early traction through rapid deployment of expert-approved templates, enabling go-live in under 30 days without heavy staff involvement.[2] A pivotal moment came with its $10M funding round backed by Blume Ventures, Together Fund, DeVC, and Medmountain Ventures, fueling expansion beyond scheduling into broader operations like transitions of care and at-risk patient identification.[1] This funding aligned with explosive growth, scaling patient access 10x in just eight months ending around mid-2025.[1]
Confido rides the wave of AI automation in healthcare operations, targeting a market strained by staffing shortages, rising patient volumes, and fragmented access—where phone systems fail to resolve most calls efficiently.[1] Timing is ideal amid 2025's maturation of voice AI and RPA, accelerated by post-pandemic telehealth demand and private equity consolidation of clinics, allowing Confido to unify experiences and cut overhead for scaling operators.[1] Favorable forces include EHR interoperability mandates and reimbursement incentives for proactive care (e.g., transitions of care reducing readmissions), positioning Confido to influence ecosystems by freeing staff for high-value work and standardizing patient interactions across specialties.[1][2]
Confido Health is primed for accelerated expansion post its $10M raise, likely deepening EHR integrations, entering new verticals, and targeting larger PE-backed networks amid AI's healthcare boom.[1] Trends like multimodal AI (voice + text + predictive analytics) and value-based care will shape its path, potentially boosting automation to 90%+ and readmission reductions. Its influence may evolve from operational relief to ecosystem enabler, powering proactive care at scale and redefining the patient front door—echoing its mission to transform healthcare's call bottleneck into seamless access.[1][2]
Confido Health has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2025 | $10.0M Series A | Battery Ventures, Blume Ventures, Khosla Ventures, Okta Ventures, Storm Ventures |